Alibaba DAMO Academy recently announced that its self-developed liver cancer AI model, 'DAMO LiON,' has made a breakthrough in real-world clinical trials.
China's Mech-Mind Robotics Technologies is set to open its order book for a Hong Kong initial public offering that could raise approximately $300 million.